Prevalence of thyroid disorders in hepatitis C virus positive patients on interferon and antiviral therapy
Authors:
Open Access
- 1 January 2016
- journal article
- research article
- Published by Medknow in International Journal of Applied & Basic Medical Research
- Vol. 6 (4) , 245-248
Abstract
Background: Hepatitis C virus (HCV) infection is common worldwide. The treatment typically involves a combination of interferon-alpha (IFN-α) and ribavirin (RBV) therapy; however, the use of IFN-α is well documented to be associated with thyroid disease, the most common autoimmune disorder associated with IFN-α. Aim: The aim of the present study was to know the prevalence of thyroid abnormality in the HCV-positive patients on IFN and antiviral therapy. Materials and Methods: Fifty known HCV positive patients were enrolled for the study. All the patients were on IFN (3 million unit subcutaneously 3 times/week) and antiviral therapy (oral RBV 1000–1200 mg/day). Thyroid function tests were performed first at the start of treatment and then after 12 weeks of treatment. Results: 13 (26%) of the patients were found to develop hypothyroidism, and 1 (2%) patient developed hyperthyroidism in the course of 12 weeks therapy. Conclusion: HCV patients on IFN and antiviral therapy have an effect on the thyroid gland, so these patients should be regularly screened for thyroid disorders and appropriately treated to maintain euthyroid status.Keywords
This publication has 19 references indexed in Scilit:
- Frequency of Thyroid Dysfunctions during Interferon Alpha Treatment of Single and Combination Therapy in Hepatitis C Virus-Infected Patients: A Systematic Review Based AnalysisPLOS ONE, 2013
- Association of Interferon-Alpha and Ribavirin-Induced Thyroid Dysfunction with Severity of Disease and Response to Treatment in Pakistani Asian Patients of Chronic Hepatitis CHepatitis Research and Treatment, 2012
- Interferon Alpha Treatment and Thyroid DysfunctionEndocrinology and Metabolism Clinics of North America, 2007
- Syndromes and complications of interferon therapyCurrent Opinion in Rheumatology, 2007
- Thyroid Disorders in Chronic Hepatitis C Virus InfectionThyroid®, 2006
- The clinical and physiological spectrum of interferon‐alpha induced thyroiditisHepatology, 2006
- Increased Level of Interferon‐α in Blood of Patients with Insulin‐Dependent Diabetes Mellitus: Relationship with Coxsackievirus B InfectionThe Journal of Infectious Diseases, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- The InterferonsJAMA, 1991
- The interferons. Mechanisms of action and clinical applicationsJAMA, 1991